David R Cooper Selected Research

holo-(acyl-carrier-protein) synthase

1/2018

Differences in substrate specificity of V. cholerae FabH enzymes suggest new approaches for the development of novel antibiotics and biofuels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R Cooper Research Topics

Disease

3	COVID-19 02/2021 - 07/2020
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 04/2003 - 03/2002
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Anthrax 01/2020
1	Infections 01/2018
1	Cholera 01/2018
1	Classical Lissencephalies and Subcortical Band Heterotopias 11/2007
1	Blindness (Hysterical Blindness) 09/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
3	Pharmaceutical PreparationsIBA 02/2021 - 07/2020
2	AlbuminsIBA 09/2020 - 07/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2020 - 07/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2020 - 07/2020
2	Neurofibromin 2 (Merlin)IBA 04/2003 - 03/2002
1	Recombinant ProteinsIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	holo-(acyl-carrier-protein) synthaseIBA 01/2018
1	Dyneins (Dynein)IBA 11/2007
1	SynteninsIBA 04/2003

Therapy/Procedure

2	Therapeutics 09/2020 - 07/2020
1	Synchrotrons 02/2021